Morgan Stanley
CHNGU

Morgan Stanley’s Change Healthcare Inc. Tangible Equity Units CHNGU Stock Holding History

Morgan Stanley’s Portfolio CHNGU Stock Details CHNGU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-30,388
Closed -$2.24M – 8215
2022
Q2 		$2.24M Sell
30,388
-942
-3% -$71.1K ﹤0.01% 4441
2022
Q1 		$2.21M Sell
31,330
-15,000
-32% -$1.01M ﹤0.01% 4448
2021
Q4 		$3.26M Buy
46,330
+46,327
+1,544,233% +$3.22M ﹤0.01% 4172
2021
Q3 		$0 Sell
3
-2,526
-100% -$184K ﹤0.01% 8149
2021
Q2 		$193K Buy
2,529
+2,526
+84,200% +$195K ﹤0.01% 6036
2021
Q1 		$0 Sell
3
-4,040
-100% -$316K ﹤0.01% 7630
2020
Q4 		$261K Buy
4,043
+2,098
+108% +$124K ﹤0.01% 5451
2020
Q3 		$103K Sell
1,945
-40,000
-95% -$1.92M ﹤0.01% 5425
2020
Q2 		$1.81M Buy
41,945
+20,500
+96% +$913K ﹤0.01% 3680
2020
Q1 		$959K Sell
21,445
-101,840
-83% -$5.39M ﹤0.01% 3991
2019
Q4 		$7.4M Buy
123,285
+122,857
+28,705% +$6.31M ﹤0.01% 2761
2019
Q3 		$21K Buy
+428
New +$22.9K ﹤0.01% 6005

Morgan Stanley's CHNGU Position: Q3 2022 in Review

Morgan Stanley sold out of Change Healthcare Inc. Tangible Equity Units (CHNGU) in Q3 2022, closing a stake of 30,388 shares — an estimated $2.24M sold.

Morgan Stanley first reported a position in CHNGU in Q3 2019 and held it in 12 quarters. The position peaked at $7.4M in Q4 2019. 0 funds tracked by Wall St. Rank hold CHNGU as of Q3 2022.

  • Morgan Stanley reported no remaining Change Healthcare Inc. Tangible Equity Units position as of Q3 2022 after selling out during the quarter.
  • Morgan Stanley sold 30,388 Change Healthcare Inc. Tangible Equity Units shares in Q3 2022, an estimated $2.24M.
  • Morgan Stanley first reported a position in Change Healthcare Inc. Tangible Equity Units in Q3 2019 and held it in 12 quarters.
  • Morgan Stanley's Change Healthcare Inc. Tangible Equity Units position peaked at $7.4M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Change Healthcare Inc. Tangible Equity Units as of Q3 2022.

Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.